Submitted by Anonymous (not verified) on 9 April 2025 - 16:00
Human medicines European public assessment report (EPAR): Hulio, adalimumab, Date of authorisation: 17/09/2018, Revision: 18, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Hulio, adalimumab, Date of authorisation: 17/09/2018, Revision: 18, Status: Authorised